Summary

  • 2001 AREDS study: 80mg zinc + antioxidants clinically proven to help reduce the risk of AMD progression and associated vision loss.*1,2

  • 2013 AREDS Extension Study – long-term benefits of original PreserVision AREDS 80mg zinc + antioxidants formula confirmed at 10 years*

  • 2013 AREDS2 Study results lead the NEI to support an updated AREDS formula,with lutein and zeaxanthin replacing beta-carotene 3,4

  • PreserVision AREDS 2 contains the exact levels of all 6 nutrients recommended by the NEI


To view the AREDS2 study results presentation from the 2013 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Click here >>.


*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

References: